Epistem is committed to providing reliable, innovative and transferable models and services to support decision making throughout the drug discovery, development and early clinical pipeline.
Epistem is an established and successful global organisation with a central facility in Manchester, UK, a laboratory in Baltimore, MD. Founded in 2000 on ground-breaking research in epithelial stem cell biology, this knowledge and expertise has been translated into a suite of models, assays and services. Epistem continues to provide a personalised service to a range of customers from virtual start-ups to established biotechnology enterprises, global pharmaceutical and personal care companies.
Epistem's technical team has a wealth of experience taking novel therapeutic agents from early stage in vitro testing to clinical candidate nomination and clinical trial support. The team can assist and advise on appropriate models and plan and manage custom protocols in accordance with the study objectives. Epistem's helpful and knowledgeable project managers are on hand to provide support throughout the duration of the study.
Epistem continues to develop innovative and clinically relevant assays and models to support the drug discovery and development pipeline. In addition to in-house development, Epistem also collaborates with commercial and academic partners to develop and validate novel, state-of-the-art models.
For more information about Epistem's Contract Research Services please contact us.